Pyc Therapeutics Ltd has released a press release.
Successful Time - Course Studies in Animals
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Response to ASX Aware Query
- Phylogicas Technology is Effective in Human Cells
- Company Presentation - July 2019
- Operational Update and Appendix 4C
- Animal Models - 400% Outperformance of Gold Standard
Later from PYC Therapeutics
- Successful Competitive Drug Evaluation in Animals
- Strategic Partnership and Lead Program
- Successful Major Milestone - Human Retina in a Dish Models
- Sept 2019 Quarterly Shareholder Update and Appendix 4C
- $26.8m Fully Underwritten Accelerated Entitlement Offer
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics